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Background: There has been resurgent interest in coronary revascularization
performed on the beating heart. Heretofore, there has been no long-term
comparison of this technique to traditional coronary artery bypass with
cardioplegia. Objective: The purpose of this study was to provide a comparison
of long-term survival and intervention-free outcome between patient groups
subjected to coronary bypass accomplished with or without the use of cardio-
pulmonary bypass. Method: From June 1989 to July 1990, all patients treated
for coronary revascularization by three surgeons were considered for coronary
revascularization with the heart beating: 107 patients underwent coronary
bypass on the beating heart, and 112 patients underwent revascularization
with the aid of bypass with cardioplegia. Mean ages (65 6 10 years) and risk
factors were identical. Patients operated on with the heart beating had 2.4 6
0.9 grafts versus 3.2 6 1.1 grafts for patients having cardiopulmonary bypass
with cardioplegia. Results: At 7-year follow-up, 86 of 107 (80%) patients
operated on with the heart beating were alive versus 88 of 112 (79%) patients
in whom cardiopulmonary bypass with cardioplegia was used. Cardiac deaths
occurred in 13 of 107 (12%) patients in the former group versus 10 of 112 (9%)
patients in the latter group. However, 32 of 107 patients operated on with the
heart beating (30%) needed catheterization for their symptoms versus 18 of
112 (16%) patients in the bypass with cardioplegia group (p 5 0.01). This
results in 21 of 107 (20%) patients in the beating heart group needing
angioplasty or a second coronary bypass versus only 8 of 112 (7%) patients in
the bypass with cardioplegia group. No patient in the bypass with cardioplegia
group required reoperation. Most of the reinterventions for the beating heart
group were percutaneous transluminal coronary angioplasty (15 of 21 [71%]
patients). Conclusion: Despite one less graft per patient, survival and cardiac
death rates were similar for the two groups. However, twice as many patients
in the beating heart group required recatheterization (30% versus 16%), and
20% needed a second intervention. Only 7% of the bypass with cardioplegia
group required reintervention. Limited revascularization of the beating heart
provides long-term results comparable to full revascularization with cardio-
pulmonary bypass, but at the cost of a threefold increase in reinterventions.
(J Thorac Cardiovasc Surg 1998;115:1273-8)
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The severity of complications associated with cor-onary artery bypass grafting (CABG) by cardio-
pulmonary bypass (CPB) are legion and often re-
ported.1, 2 Attempts to decrease this morbidity,
shorten hospital stay, and hasten recovery time have
resulted in renewed interest in revascularizing the
beating heart (BH) without CPB via either full or
partial sternotomy or anterior thoracotomies.3 The
apparent advantages of eliminating CPB must be
weighed against the presumed disadvantages of op-
erating on a moving field and encountering access
problems to all areas of the heart, which may limit
the number of vessels that can be bypassed. To date,
the technical feasibility of BH CABG has been
demonstrated by a number of investigators using a
myriad of techniques.1, 3 However, heretofore, there
existed no long-term comparison or follow-up on a
large cohort of patients who have undergone myo-
cardial revascularization concurrently with either
CPB-supported CABG (indicated hereafter as
CPB) or without CPB (BH). Beginning in the
summer of 1989, emboldened by the training that
one of us had received with Frederico Benetti of
Argentina, three attending surgeons at Loma Linda
University Medical Center considered revascular-
ization with a BH for all patients in need of myo-
cardial revascularization and continued to offer this
approach for 1 year. In that year, 107 patients under-
went successful operations with BH; 112 patients were
deemed unsuitable for this approach and had tradi-
tional CPB. Thus, by mere serendipity, two nearly
equal groups were available for long-term follow-up.
Patients and methods
All patients seen by the senior author and two other
attending surgeons at Loma Linda University Medical
Center during the period from June 1989 to July 1990
were offered the opportunity to have their revasculariza-
tions performed without CPB. We were encouraged by
the return of one of the surgeons from several months of
direct training in this technique by Frederico Benetti in
Buenos Aires, Argentina. If consent was obtained from
the patient, the choice of performing the operation with-
out CPB was left to the operating surgeon and was often
decided in the operating room. BH CABG was performed
with silicone rubber tapes around the coronary arteries
proximal and distal to the anastomosis. Heart rate was
slowed with intravenous beta blockage; blood pressure
was supported by phenylephrine intravenously. Thermodi-
lution cardiac output for all patients was determined
periodically. Anastomosis visualization was aided by ei-
ther fine suction or continuous warm saline solution irriga-
tion. Proximal anastomoses were usually constructed first.
CPB CABG was performed with dual-stage venous cannula
drainage, moderate systemic hypothermia, and antegrade
and/or retrograde cold blood cardioplegic solution (2:1 dilu-
tion). Proximal anastomoses were constructed with a partial
occlusion clamp on the ascending aorta.
Statistical analysis
Comparison between the two groups was accomplished
with the x2 test with the Casio Statistical Package (Casio
Computer Company, Tokyo, Japan). Results are given as
mean 6 standard deviation.
Results
At the end of 1 year, 107 patients had successfully
undergone the operation with BH, and 112 patients
had undergone CPB. Mean patient age was identical
at 65 6 10 years. No risk stratification was per-
formed but, in general, patients believed to have
more difficult problems, either from anatomic or
ejection fraction criteria, were treated with CPB.
A total of 260 vessels in 107 patients were by-
passed in the BH group (2.4 6 0.9 vessels per
patient) versus 362 vessels in 112 patients with CPB
(3.2 6 1.1 vessels per patient); the distribution of
vessels bypassed can be seen in Table I. Almost all
patients had a bypass performed to the left anterior
descending coronary artery (LAD; 88% vs 86% with
a BH vs CPB, respectively) although 81% versus
96%, respectively, had an internal thoracic artery
used (p 5 0.8). A much higher proportion of obtuse
marginal (100% vs 62%) and posterior descending
vessels (46% vs 16%) were bypassed in the patients
with CPB, reflecting our relative difficulty in ap-
proaching these vessels without CPB. In essence,
one less vessel per patient was performed in the BH
group, primarily in the obtuse marginal and poste-
rior descending distributions. Patients recovered
and were followed for the next 6.5 to 7.5 years, with
Table I. Comparison of initial bypasses
Vessels bypassed Pump (%) Beating heart (%)
LAD 96 (86) 94 (88)
Internal thoracic artery 15 (13) 14 (18)
1st diagonal 30 (26) 19 (17)
2nd diagonal 16 (14) 12 (11)
1st obtuse marginal branch 45 (40) 33 (31)
2nd obtuse marginal
branch
19 (17) 3 (3)
3rd obtuse marginal branch 50 (45) 26 (24)
Posterolateral branch 9 (8) 5 (5)
Posterior descending artery 52 (46) 17 (16)
Right coronary artery 29 (26) 37 (35)
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follow-up completed in January 1997. Follow-up
data were obtained from patient records; if a patient
had not received medical follow-up within 1 month
of chart review, a telephone call was made to the
patient and/or referring physician. Follow-up was
100% complete. Patients were compared for return
for cardiac catheterization both in number and time
from operation, deaths, cardiac deaths, additional
cardiac procedures (percutaneous transluminal cor-
onary angioplasty [PTCA] and/or stents), redo
CABGs, vessels patent or occluded as seen on an
angiogram, and current symptomatic status.
At the 7-year follow-up, 86 of the 107 patients
who underwent BH bypass are alive (80%) versus 88
of the 112 patients who underwent CABG (79%;
p 5 0.8). Of the 21 BH deaths, 13 (62%) were
cardiac related; of the 24 CPB deaths, 10 (42%)
were cardiac related (p 5 0.3).
A total of 30 (30%) patients who had a BH bypass
underwent 32 catheterizations during the 7 years; 16
(16%) patients with CPB had 18 catheterizations(p 5
0.01). Time to treatment for catheterization was iden-
tical between the two groups (mean, 32 6 26 months
vs 32 6 23 months, respectively) (Fig. 1), although
several patients who had undergone revascularization
with BH clustered early after bypass.
A total of 34 catheterizations were available for
direct visualization (21 BH and 13 CPB) by the
senior author. Patency as determined by the cardi-
ologist and confirmed by the senior author is shown
in Table II. Patients who had undergone CPB had
12 of the 13 LAD grafts (92%) versus 7 of the 15 BH
grafts (47%); 7 of the 13 patients had right coronary
artery or patent ductus arteriosus grafts (54%)
versus 3 of the 13 BH grafts (23%) and overall
patency of 31 of the 41 (72%) CPB grafts versus 12
of the 35 (34%) BH grafts. Of note, three of the
internal thoracic artery/LAD grafts in the patients
who had BH bypass had significant stenoses at the
site of vessel loops.
Twenty-one of the 107 (20%) patients who had
undergone BH bypass required 22 interventions
versus 6 (7%) patients who required 8 interventions
in the CPB group. Sixteen patients who had under-
gone BH bypass underwent PTCAs (one repeat); an
additional five (5%) patients required redo CABG.
The only interventions required in the CPB group
were PTCAs. One patient who had undergone CPB
required two PTCAs. One patient who had had BH
bypass died after redo CABG; one patient who had
had CPB died of a pulmonary embolus 5 days after
a cardiac catheterization.
Post-CABG PTCAs differed markedly between pa-
tients who had undergone BH bypass and who had
undergone CPB (Table III). In the patients with BH
bypass, 12 PTCAs were performed on a vessel that had
been previously bypassed and on only four vessels that
had not been bypassed; in the patients who had
undergone CPB, only two PTCAs were performed on
previously bypassed vessels, and six PTCAs were per-
formed on vessels previously unbypassed.
Comment
CABG on the BH has been used since the incep-
tion of coronary revascularization4, 5 but has rarely
been applied on a consistently large enough scale
until it was revived by Benetti6 and Buffolo and
coworkers7 in the mid-1980s. The technique flour-
Fig. 1. Time after the operation for catheterization between patients who had BH bypass and who had
CPB CABG.
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ished briefly in the early 1990s in the United States
but was largely abandoned. In the past few years, the
technique was reapplied via smaller incisions, most
notably a left anterior thoracotomy or partial ster-
notomy, to accomplish bypass to the LAD and/or
right coronary artery.8, 9 Although short-term results
appear encouraging, heretofore, no long-term stud-
ies were available to compare BH bypass to conven-
tional bypass techniques.
The results of this 7-year follow-up among two
patient groups simultaneously receiving either BH
bypass or conventional bypass (CPB) reveals that
either policy results in similar outcomes in death
and cardiac causes of death, although it must be
observed that generally patients in less favorable
condition were operated on with CPB. This finding
occurs despite the use of one less graft per patient in
the BH group. Most patients receiving either ther-
apy were asymptomatic at the 7-year follow-up (71%
BH vs 84% CPB), implying significant graft patency
in both groups. Despite these similarities, significant
differences in subsequent therapies emerged be-
tween the two treatment modalities. Specifically,
approximately one third of the patients who under-
went BH bypass required catheterization for re-
newed anginal symptoms, which resulted in 17
PTCAs and 5 reoperations (20%). In contrast, only
16% of the patients who had CPB experienced
anginal symptoms requiring catheterization, result-
ing in eight PTCAs and no reoperations (7%). In
other words, parity between groups was achieved
only by using three times as many postbypass inter-
ventions in the BH group.
Although the reintervention rate was higher in
the BH group, this needs to be compared not only
with CPB as primary therapy but also with the
results of PTCA as a management strategy for
coronary artery disease. In a 10-year follow-up of an
initial strategy of PTCA in 856 patients, as described
by Ruygrok and coworkers,10 220 patients (26%)
required subsequent CABG and an additional 221
patients (26%) underwent further angioplasty.
Comparing our current study with this, it would
appear that BH bypass produces results intermedi-
ate between conventional bypass (best) and angio-
plasty (worst). It further suggests that limited revas-
cularization, by either PTCA or BH bypass, will
produce long-term results comparable to full revas-
cularization, but only if one accepts the need for
additional procedures later. Interestingly, despite
less than full revascularization in the BH group,
subsequent PTCAs were usually directed at previ-
ously bypassed vessels, rather than nonbypassed
targets. This also implies, but does not prove, that an
initial strategy of PTCA of those vessels may have
been equally effective.
Our study, somewhat surprisingly, also revealed
that the time of presentation for renewed symptoms
after the procedure was identical between groups at
approximately 2.5 years (although several patients
who underwent BH bypass clustered early [Fig. 1]).
Because all patients had a negative stress test at the
time of discharge, early graft patency did not imply
late (several year) patency, making a policy of
predicting graft behavior on 1-day or 1-month an-
giography risky.11
Several techniques used in our BH group deserve
mention and perhaps criticism. Our technique used
a full sternotomy; every attempt was made to
achieve full revascularization. This must be con-
trasted against current suggestions that very limited
revascularization (i.e., an internal thoracic artery
onto an LAD) is sufficient for patients with multives-
sel disease. Although full sternotomy is useful to
access most regions of the heart off bypass, opening
of the pericardium allows significant cardiac motion,
which may affect the technical quality of the anas-
tomosis. A limited approach may lessen cardiac
movement and improve graft patency. Our policy of
using soft, cushioned silicone rubber tapes around
the coronary arteries should also be questioned.
These tapes produce a broad area of contact with
the coronary artery and may, therefore, produce
more, rather than less, endothelial cell damage.12
Furthermore, the use of these tapes to aid in vessel
stabilization produces significant tension on the
coronary arteries and may produce stenoses distal or
proximal to the anastamosis. Newer stabilization
devices may further enhance anastomotic quality
Table II. Patency rates of post-CABG of those
patients who underwent angiography
LAD RCA/PDA All grafts
Open (%) Closed Open (%) Closed Open (%) Closed
BH 7 (41) 8 3 (23) 10 12 (34) 23
CPB 12 (92) 1 7 (54) 6 31 (72) 10
RCA, Right coronary artery; PDA, posterior descending artery.
Table III. Vessels bypassed and subsequent PTCA
PTCA same vessel PTCA different vessel
BH (No. of patients) 12 4
CPB (No. of patients) 2 6
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and improve late patency,13 but this remains specu-
lative.
The results of our study suggest that multivessel
BH CABG has the potential to produce late mor-
tality rates equal to that of conventional bypass
operations; but, in exchange, additional procedures
may be needed in a number of patients. Thus we
advise patients in advance that additional proce-
dures may be needed if BH revascularization is
desired. Nevertheless, multivessel BH bypass would
appear to be more efficacious than a policy of PTCA
alone.
In conclusion, multivessel CABG performed on
the BH appears capable of producing equivalent
longevity and symptomatic status 7 years after the
operation when compared with a similar cohort of
patients receiving conventional bypass. However,
twice as many patients who had undergone BH
bypass required catheterization, and three times as
many reinterventions were required to achieve par-
ity with conventional bypass techniques. We recom-
mend that patients be fully informed of these late
results before embarking on a course of BH revas-
cularization.
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Discussion
Dr. Federico J. Benetti (Buenos Aires, Argentina). Al-
though the study you present is retrospective and the
groups you compare are difficult to match at the time of
your analysis, it is clear that the results describe a learning
curve in this procedure. I would like to share the following
observations:
We began our experience of off-pump bypass with
LAD, diagonal, and right bypasses; after a period of time,
we moved to the circumflex system. We never performed
more than 20% of circumflex grafts in our experience. In
our first 400 patients in BH surgery, we achieved 90%
survival in 7 years. In this group approximately 12% of the
patients underwent recatheterization at around 3.5 to 4
years. Of these cases, approximately one half of them
needed other treatment, most of them PTCA. It was
interesting for us to find that 91% of the grafts in the LAD
were patent. Our experience also reflects a learning curve,
yet our patency rate seems much higher in the LAD. Dr.
Buffolo of Brazil also has an interesting experience com-
paring, prospectively, thoracic artery to LAD with pump
and without pump. He had similar patency rates to our
experience of 93% in both groups.
Although the discrepancy between the authors’ experi-
ence and our experience seems great, both analyses are
weakened by the fact that only a few patients were
restudied based on symptoms rather than a more random
sample. The analysis is therefore biased based on symp-
toms. Additionally, the authors state that no preoperative
risk stratification was performed; therefore comparison
between the two groups is somewhat less reliable for
interpretation of outcomes.
The data of the initial cardiothoracic surgery registry in
which 508 patients in 34 different groups all over the world
with LAD mechanical stabilization systems show a 94%
patency rate. This experience includes centers with small
experiences in BH surgery and also reflects a learning
curve. Additionally, Drs. Calafiore and Subramanian have
presented large series of BH surgery in which the patency
rate in the LAD has reached more than 97%. It is still
early to tell what long-term patency will look like with
improved techniques and new technology for coronary
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stabilization. Early reports for 1-year follow-up are very
encouraging.
Dr. Gundry honestly recognizes that there are a lot of
technical issues in this initial series. Dr. Gundry concluded
that outcomes of death and symptoms were the same in
both groups, although the need for reintervention ap-
peared to be three times greater in the BH group. I
believe this is the most important finding of this paper,
that the outcome of survival is the same with or without
pump support.
We know CPB has morbidities that we would like to
avoid, especially in high-risk groups. We also know today
that left internal thoracic artery to LAD is the most
important predictor of event-free survival. The concern of
the paper in terms of reintervention in the BH group can
be resolved with improvement in the technique and
advancement of the learning curve.
With the results we have today, such as good early
angiographic patency, very low incidences of complica-
tions, and mortality rates in the minimally invasive left
internal thoracic artery to LAD, how many patients need
more than that in the different situation of coronary
disease?
Thank you again, Dr. Gundry, for highlighting the point
that with technical improvements, BH surgery can possi-
bly offer the best option for the patient.
Dr. Marko I. Turina (Zurich, Switzerland). What is your
impression about the cause of this obstruction? Is it more
an anastomosis-related problem, or is it the restraining
devices put on the artery to control the backflow?
Dr. Gundry (Loma Linda, Calif.). Having reviewed this
personally on all the angiograms, there is a fairly even
distribution between anastomotic narrowing and narrow-
ing at the site of our vessel occluders.
Now, as I mentioned in the article, we use those vessel
occluders to actually help stabilize the anastomosis. I have
abandoned that practice on the basis of our angiograms
because I think this really does denude a large area of
endothelium. That problem may not be noticed for a long
period of time because smooth muscle prevalence takes
place there. So I think that, with the newer stabilization
devices in which snares are not used to actually help stabilize
the vessel, I would anticipate that problem would lessen.
Now, can I address Dr. Benetti’s comments. Dr.
Benetti, it was your leadership that really led us to this
provocative study nearly 8 years ago.
Your survival statistics are identical with ours at 7 years
of about 90%, and that probably speaks to the consistency
and reproducibility of this technique.
I think patency will get better. It certainly did in our
learning curve; I believe with the newer stabilization
devices, we do construct a better anastomosis.
Your point as to how many vessels one actually needs
to maintain reliable long-term myocardial revascular-
ization and relief of angina is the fundamental question
that needs to be addressed before any of these tech-
niques are going to be widely adapted. Certainly in our
study, one less vessel bypass per patient did not result in
long-term harm in terms of cardiac deaths. However,
the price we seem to have paid was an increase in
PTCAs and recatheterizations. I think it is up to the
patient and perhaps the referring cardiologist and
perhaps third-party payers to decide whether this pen-
alty is worth the initial price.
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